Onsite and In Person The decision to hold an in-person meeting in 2021 was made with great consideration for the safety of all attendees, guests, and participants. ASCRS continues to work with the convention center, hotels, event management partner, and all vendors to ensure the highest level of precautions are taken for the meeting. For the most up to date health and safety…
In honor of the 50th anniversary of ASCRS, member ophthalmologists from the 50 states are sending in their perspectives on the Society, its impact on…
Two physicians detailed Ocular Surface Stem Cell Transplantation with Systemic Immunosuppression for the treatment of severe ocular surface disease with limbal stem cell deficiency and…
ASCRS YES members receive this monthly newsletter that features the latest news, events, and YES-specific opportunities.
ASCRS Foundation More than 85 million people are visually impaired worldwide. The ASCRS Foundation delivers humanitarian eye care and treats thousands of patients each year.…
ASCRS Live! is gathering local ophthalmologists for dinner and to foster connection and discussion about the hottest topics in anterior segment surgery. This event is…
➤ First patient enrolled in Phase 3 trial evaluating phentolamine ophthalmic solution ➤ FDA clears IND amendment for Phase 3 retinitis pigmentosa gene therapy study…
Identifying and treating patients with limbal stem cell dysfunction or deficiency can be a challenging process. Several physicians discussed how they handle these patients, including…
For the first time ever, ASCRS Grand Rounds is opening the program up for case submissions from residents and fellows, but only for a limited…
Peripheral ulcerative keratitis is an inflammatory condition that typically affects the peripheral cornea leading to corneal thinning and corneal melt. It is commonly associated with…
Maintaining roots in cataract and refractive surgery, while expanding to all of the anterior
